Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Jan. 19, 2000

Pharmacia & Upjohn and Searle to copromote Detrol

Jan. 11, 2000

FDA informs Urologix of new developments concerning the Targis System

Jan. 6, 2000

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

Once-daily oxybutynin assessed in urinary urge incontinence

Dec. 27, 1999

Vivus seeks FDA approval for new impotence drug

Dec. 23, 1999

Vasomax progress updated by Zonagen

Dec. 22, 1999

NexMed initiates phase II trials of alprostadil cream in U.S.

Dec. 22, 1999

Milestone for Gene Logic in kidney disease collaboration

Dec. 21, 1999

Herbomineral preparation shows efficacy in animal model of BPH

Dec. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...